News Bio-Rad Laboratories, Inc.

Stocks

BIO

US0905722072

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 04:00:02 2026-09-04 pm EDT			5-day change	1st Jan Change
386.11 ^USD	-0.46%		-0.41%	+27.43%

Aug. 07	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
Aug. 05	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT

All News

Mentions Relevance

Aug. 31	Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 21st Annual Healthcare Conference	BU
Aug. 07	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
Aug. 05	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT
Aug. 04	Bio Rad Laboratories : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)	PU
Aug. 04	Bio-Rad Laboratories, Inc., Q2 2026 Earnings Call, Aug 04, 2026
Aug. 04	Bio-Rad: Q2 Earnings Snapshot	AQ
Aug. 04	Bio-Rad Laboratories Q2 Adjusted Earnings Rise, Revenue Falls	MT
Aug. 04	Bio-Rad Laboratories, Inc. Provides Earnings Guidance for the Third Quarter of 2026	CI
Aug. 04	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q2 Revenue $651.0M, vs. FactSet Est of $624.0M	MT
Aug. 04	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q2 Adjusted EPS $2.62 per Share, vs. FactSet Est of $1.75	MT
Aug. 04	Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on July 20, 2023.	CI
Aug. 04	Bio-Rad Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
Aug. 04	Bio-Rad Reports Second-Quarter 2026 Financial Results	BU
Jul. 23	Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026	BU
Jun. 03	Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM
May. 19	Bio-Rad Laboratories, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2026, May-19-2026 08:30 AM
May. 18	Bio-Rad Laboratories Draws Elliott Investment as Activist Investor Pushes for Turnaround	MT
May. 18	Elliott Investment Management LP Urges Improvement In Share Price And Value Creation for Shareholders	CI
May. 17	Elliott builds big stake in life-science tools supplier Bio-Rad Labs, WSJ reports	RE
May. 17	Activist investor Elliott builds stake in life-science tools supplier Bio-Rad Laboratories, WSJ reports	RE
May. 17	Activist Elliott Investment Management has built a sizable stake in Bio-Rad Laboratories - WSJ	RE
May. 15	Bio-Rad Laboratories' Sales Growth Set to Recover in 2027, RBC Says	MT
May. 11	Bio-Rad to Participate in Upcoming Investor Conferences	AQ
May. 08	Bio-Rad to Participate in Upcoming Investor Conferences	BU
May. 01	Bio-Rad Laboratories, Inc., Q1 2026 Earnings Call, Apr 30, 2026